KALY

Kali, Inc. KALY

KALY
Kali, Inc. ACUR
Acura Pharmaceuticals, Inc. FLHLF
Filament Health Corp. CBDX
Curative Biosciences, Inc. TNPH
Tian'an Pharmaceutical Co., Ltd. AZFL
Amazonas Florestal, Ltd CNNC
Cannonau Corp. NNRX
Nutranomics, Inc. MRRCF
Wayland Group Corp. GMVDF
G Medical Innovations Holdings Ltd

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode KALY ACUR FLHLF CBDX TNPH AZFL CNNC NNRX MRRCF GMVDF
6M 0.00 % -80.00 % -99.50 % 0.00 % 54.17 % 0.00 % -40.00 % -50.00 % 0.00 % 0.00 %
YTD 4 900.00 % 150.00 % -99.75 % 0.00 % -28.85 % 9 900.00 % 0.00 % -50.00 % -90.00 % -50.00 %
1Y -50.00 % -85.71 % -99.61 % 0.00 % -28.85 % 9 900.00 % 50.00 % -50.00 % -90.00 % -50.00 %
3Y 499 900.00 % -99.00 % -99.75 % -95.00 % -90.51 % -50.00 % -98.57 % -50.00 % 900.00 % -100.00 %
5Y 49 900.00 % -99.77 % -99.97 % -93.47 % -89.46 % -50.00 % -99.90 % -83.33 % -99.75 % -100.00 %
10Y 150.00 % -99.98 % -99.97 % -97.78 % 3 600.00 % -99.90 % 59 900.00 % -93.75 % -99.90 % -100.00 %
Depuis le début -99.83 % -100.00 % -99.97 % -100.00 % -99.61 % -100.00 % 93.55 % -99.96 % -100.00 % -100.00 %

Dividende